GRI Index
Transcription
GRI Index
1 GRI INDEX This report is aligned with the Global Reporting Initiative (GRI) G3.1 Sustainability Reporting Guidelines, at an application level of B+. To locate the elements and information contained within the guidelines, use the index below. Key FULLy Reported PARTIAL Reported Standard disclosures part i: profile disclosures Profile disclosure Disclosure Level of reporting Location of disclosure Page 1. Strategy and analysis 1.1 Statement from the most senior decision-maker of the organization. 2012 CSR Report – Introduction, Senior management interview 3 1.2 Description of key impacts, risks, and opportunities. 2012 CSR Report – Introduction, Senior management interview 3 2012 CSR Report – Introduction, About CSR at Sanofi 6 2012 CSR Report – Introduction, Our material issues 7 2. Organisational profile 2.1 Name of the organization. 2.2 Primary brands, products, and/or services. Our products (http://en.sanofi.com/ products/products.aspx), Form 20-F 2012 – Part I - Item 4 - ((http://en.sanofi.com/investors/ news/news.aspx) 20-21 2.3 Operational structure of the organization, including main divisions, operating companies, subsidiaries, and joint ventures. Form 20-F 2012 – Part I - Item 4 - (http://en.sanofi.com/investors/ news/news.aspx) 19 & 83 2.4 Location of organization’s headquarters. Paris 2.5 Number of countries where the organization operates, and names of countries with either major operations or that are specifically relevant to the sustainability issues covered in the report. 2012 CSR Report – Introduction, Group profile 2 2.6 Nature of ownership and legal form. Form 20-F 2012 – Part I - Item 4 - (http://en.sanofi.com/investors/ news/news.aspx), Sanofi Share (http://en.sanofi.com/investors/ share/share.aspx) 21 2.7 Markets served (including geographic breakdown, sectors served, and types of customers/beneficiaries). 2012 CSR Report – Introduction, Group profile 2 2.8 Scale of the reporting organization. 2012 CSR Report – Introduction, Group profile 2 Form 20-F 2012 – Part I - Item 4 - (http://en.sanofi.com/investors/ news/news.aspx) 2, 24 & 25 2012 CSR Report – Our CSR performance, Reporting methodology 94 2.9 Significant changes during the reporting period regarding size, structure, or ownership. Front cover 2 GLOBAL REPORTING INITIATIVE Profile disclosure Disclosure 2.10 Awards received in the reporting period. Level of reporting Location of disclosure Page 2012 CSR Report – Our CSR performance, Statutory auditors’ report 96 Download Center – 2012 External CSR awards received factsheet 3. Report parameters 3.1 Reporting period (e.g., fiscal/calendar year) for information provided. 2012 CSR Report – Our CSR performance, Reporting methodology 3.2 Date of most recent previous report (if any). 2011 3.3 Reporting cycle (annual, biennial, etc). Annually 3.4 Contact point for questions regarding the report or its contents. [email protected] 3.5 Process for defining report content. 2012 CSR Report – Introduction, Our material issues 7 2012 CSR Report – Introduction, Stakeholder relations 8 94 Back cover 3.6 Boundary of the report (e.g., countries, divisions, subsidiaries, leased facilities, joint ventures, suppliers). See GRI Boundary Protocol for further guidance. 2012 CSR Report – Introduction, Reporting methodology 94 3.7 State any specific limitations on the scope or boundary of the report (see completeness principle for explanation of scope). 2012 CSR Report – Introduction, Reporting methodology 94 3.8 Basis for reporting on joint ventures, subsidiaries, leased facilities, outsourced operations, and other entities that can significantly affect comparability from period to period and/or between organizations. 2012 CSR Report – Introduction, Reporting methodology 94 3.9 Data measurement techniques and the bases of calculations, including assumptions and techniques underlying estimations applied to the compilation of the Indicators and other information in the report. Explain any decisions not to apply, or to substantially diverge from, the GRI Indicator Protocols. 2012 CSR Report – Introduction, Reporting methodology 94 3.10 Explanation of the effect of any re-statements of information provided in earlier reports, and the reasons for such re-statement (e.g., mergers/acquisitions, change of base years/periods, nature of business, measurement methods). 2012 CSR Report – Introduction, Reporting methodology 94 3.11 Significant changes from previous reporting periods in the scope, boundary, or measurement methods applied in the report. 2012 CSR Report – Introduction, Reporting methodology 94 3.12 Table identifying the location of the Standard Disclosures in the report. 2012 CSR Report – Our CSR performance, Global reporting initiative 91 Policy and current practice with regard to seeking external assurance for the report. 2012 CSR Report – Our CSR performance, Statutory auditors’ report 97 3.13 4. Governance, commitments and engagement 4.1 Governance structure of the organization, including committees under the highest governance body responsible for specific tasks, such as setting strategy or organizational oversight. Form 20-F 2012 – Part I - Item 6 - (http://en.sanofi.com/investors/ news/news.aspx) 4.2 Indicate whether the Chair of the highest governance body is also an executive officer. Form 20-F 2012 – Part I - Item 6 - (http://en.sanofi.com/investors/ news/news.aspx) 150 4.3 For organizations that have a unitary board structure, state the number and gender of members of the highest governance body that are independent and/or non-executive members. Form 20-F 2012 – Part I - Item 6 - (http://en.sanofi.com/investors/ news/news.aspx) 150-167 150-167 3 GLOBAL REPORTING INITIATIVE Profile disclosure Disclosure 4.4 Mechanisms for shareholders and employees to provide recommendations or direction to the highest governance body. 4.5 Linkage between compensation for members of the highest governance body, senior managers, and executives (including departure arrangements), and the organization's performance (including social and environmental performance). Level of reporting Location of disclosure Page 2012 CSR Report – Introduction, Stakeholder relations 8 Form 20-F 2012 – Part I - Item 6, – Part I - Item 7, – Part I - Item 10, - (http://en.sanofi.com/investors/ news/news.aspx). 181-182 194 210-211 2012 CSR Report – Senior management interview 3 Form 20-F 2012 – Part I - Item 6 - (http://en.sanofi.com/investors/ news/news.aspx) 150-167 As part of the annual appraisal process executives and senior managers are measured against Sanofi’s performance. Some executives and senior managers, directly involved in health, safety and environment and CSR, are measured against the relevant environmental and social performance. This has an impact on their compensation agreements. Business performance is also considered in compensation for all employees. Increasing female talent is now part of the bonus objectives of the Executive Committee. 4.6 Processes in place for the highest governance body to ensure conflicts of interest are avoided. Form 20-F 2012 – Part II - Item 15 & 16 - (http://en.sanofi.com/investors/ news/news.aspx) 242-243 4.7 Process for determining the composition, qualifications, and expertise of the members of the highest governance body and its committees, including any consideration of gender and other indicators of diversity. Form 20-F 2012 – Part I - Item 6 - (http://en.sanofi.com/investors/ news/news.aspx) 150-167 4.8 Internally developed statements of mission or values, codes of conduct, and principles relevant to economic, environmental, and social performance and the status of their implementation. Download Center – Policies and management systems factsheet Procedures of the highest governance body for overseeing the organization's identification and management of economic, environmental, and social performance, including relevant risks and opportunities, and adherence or compliance with internationally agreed standards, codes of conduct, and principles. 2012 CSR Report – CSR Governance 4.9 Download Center – Responsible lobbying factsheet Form 20-F 2012 – Part I - Item 6 - (http://en.sanofi.com/investors/ news/news.aspx) 4.10 Processes for evaluating the highest governance body's own performance, particularly with respect to economic, environmental, and social performance. Form 20-F 2012 – Part I - Item 6 - (http://en.sanofi.com/investors/ news/news.aspx) 4.11 Explanation of whether and how the precautionary approach or principle is addressed by the organization. Download Center – Energy carbon footprint factsheet Download Center – Risk management factsheet 4.12 Externally developed economic, environmental, and social charters, principles, or other initiatives to which the organization subscribes or endorses. 9 CSR Governance. The Senior VP of CSR presents to and discusses CSR issues with the Board on an annual basis. Download Center – Policies and management systems factsheet Download Center – Human rights factsheet 182 150-167 4 GLOBAL REPORTING INITIATIVE Profile disclosure Disclosure Level of reporting Location of disclosure 4.13 Memberships in associations (such as industry associations) and/or national/international advocacy organizations in which the organization: has positions in governance bodies; participates in projects or committees; provides substantive funding beyond routine membership dues; or views membership as strategic. Download Center – Corporate governance factsheet 4.14 List of stakeholder groups engaged by the organization. Download Center – Stakeholder engagement factsheet 4.15 Basis for identification and selection of stakeholders with whom to engage. Download Center – Stakeholder engagement factsheet 4.16 Approaches to stakeholder engagement, including frequency of engagement by type and by stakeholder group. Download Center – Stakeholder engagement factsheet 4.17 Key topics and concerns that have been raised through stakeholder engagement, and how the organization has responded to those key topics and concerns, including through its reporting. Download Center – Stakeholder engagement factsheet Download Center – Memberships & collaboration factsheet Download Center – Partnering with patient associations factsheet Download Center – CSR approach and governance factsheet Responsible Lobbying and Pharmaceuticals in the environment became CSR priorities in our strategy and reporting following increasing interest from our stakeholders for these topics. SRI investors also asked for more information about our CSR activities, therefore we held a CSR Investor meeting in 2012 see: http:// en.sanofi.com/investors/events/ corporate/2012/2012-12-17_IR_ seminar_CSR.aspx Page 5 GLOBAL REPORTING INITIATIVE Standard disclosures part ii: Disclosures on Management Approach (DMAs) Disclosure Level of reporting Location of disclosure Page Economic performance Chapter 4, document reference, Form 20-F 2012 – Part I - Item 5 (http://en.sanofi.com/investors/news/news.aspx) 90-91 Market presence Chapter 4, document reference, Form 20-F 2012 – Part I - Item 5 (http://en.sanofi.com/investors/news/news.aspx) 90-91 Indirect economic impacts Chapter 4, document reference Further comments Economic 2012 CSR Report – People, Workforce development 66 Download Center – Workforce_Development Environment Materials Download Center – HSE policy factsheet Organizational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO Download Center – Green chemistry factsheet Download Center – HSE management system factsheet Energy Download Center – HSE policy factsheet Organizational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO Download Center – Energy carbon footprint factsheet Download Center – HSE management system factsheet Water Download Center – HSE policy factsheet Organizational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO Download Center – Water management factsheet Download Center – HSE management system factsheet Biodiversity 2012 CSR Report – Planet, Pharmaceuticals in the environment 81 Organizational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO 78 Organizational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO 81 Organizational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO 81 Organizational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO 71 Organizational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO Download Center – HSE policy factsheet Download Center – Sanofi Position on biodiversity and biopiracy factsheet Download Center – HSE management system factsheet Emissions, effluents and waste 2012 CSR Report – Planet, Water management Download Center – HSE policy factsheet Download Center – Energy carbon footprint factsheet Download Center – Quality management system factsheet Download Center – Waste management factsheet/Policy/ Position Download Center – Protection of the atmosphere factsheet/ Policy/ Position Download Center – HSE management system factsheet/ Policy/Position Products and services 2012 CSR Report – Planet, Pharmaceuticals in the environment Download Center – HSE policy factsheet Download Center – HSE management system factsheet Compliance 2012 CSR Report – Planet, Pharmaceuticals in the environment Download Center – HSE policy factsheet Download Center – Protection of the atmosphere factsheet Download Center – HSE management system factsheet Transport 2012 CSR Report – Planet, Energy and carbon footprint Download Center – HSE policy factsheet 6 GLOBAL REPORTING INITIATIVE Disclosure Overall Level of reporting Location of disclosure Page Further comments 2012 CSR Report – Planet, Energy and carbon footprint 71 2012 CSR Report – Planet, Water management 78 Organizational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO Download Center – HSE policy factsheet Labour practices and decent work Employment 2012 CSR Report – People, Workforce development Labor/ management relations Download Center – Employee representation and information factsheet Occupational health and safety 2012 CSR Report – People, Health and safety in the workplace Training and education Download Center – Human rights factsheet Diversity and equal opportunity Download Center – Les enfants de Sanofi factsheet Organizational responsibility sits with the Senior VP in CSR, reporting to the CEO Equal remuneration for women and men Download Center – Les enfants de Sanofi factsheet Organisations responsibility sits with the Senior VP of Human Resources, reporting to the CEO 66 Organizational responsibility sits with the Senior VP of Human Resources, reporting to the CEO 56 Download Center – HSE policy factsheet 2012 CSR Report – People, Workforce development 66 Human rights Investment and procurement practices 2012 CSR Report – Ethics, Human rights Nondiscrimination 2012 CSR Report – Ethics, Human rights 50 Download Center – Responsible procurement factsheet 50 Download Center – Responsible procurement factsheet Download Center – Suppliers code of conduct factsheet Freedom of association and collective bargaining 2012 CSR Report – Ethics, Human rights 50 Download Center – Responsible procurement factsheet Download Center – Suppliers code of conduct factsheet Registation Document 2012 – Section 4.1.3 - page 11 (http://en.sanofi.com/investors/news/news.aspx) Child labor 2012 CSR Report – Ethics, Human rights 50 Download Center – Responsible procurement factsheet Download Center – Suppliers code of conduct factsheet Prevention of forced and compulsory labor 2012 CSR Report – Ethics, Human rights Download Center – Responsible procurement factsheet Download Center – Suppliers code of conduct factsheet Organizational responsibility sits with the Senior VP of Human Resources, reporting to the CEO 50 Organisational responsibility sits with the Head of HSE reporting to the Senior Vice President of Corporate Affairs, reporting to the CEO Organisational responsibility sits with the Senior VP of Human Resources, reporting to the CEO 7 GLOBAL REPORTING INITIATIVE Disclosure Level of reporting Location of disclosure Page Security practices The Corporate Economic Security Direction has established a policy for protection of its employees based on identification and analysis of risks, informing employees, monitoring of business travellers movements, training of employees, local expatriates and business travellers, the implementation of assistance plans, particularly in atrisk countries. The people protection department, responsible for the implementation of this policy, defines the objectives and establishes the resources to ensure this global protection. Indigenous rights Download Center – Sanofi position on biodiversity and biopiracy factsheet Assessment 2012 CSR Report – Ethics, Human rights, Supplier evaluations, Procurement 54 Remediation 2012 CSR Report – Ethics, Human rights, Supplier evaluations, Procurement 54 Local communities 2012 CSR Report – Patient, Access to healthcare, Sanofi Espoir Foundation 16 Corruption 2012 CSR Report – Ethics, Business ethics, Responsible marketing 46 2012 CSR Report – Ethics, Business ethics, Responsible lobbying 43 Further comments Society The approach the local communities is decentralised and is the responsibility of the General Manager at local level. Download Center – Sanofi Supplier Relationships Charter factsheet Public policy 2012 CSR Report – Ethics, Business ethics, Responsible lobbying 43 Anti-competitive behavior 2012 CSR Report – Ethics, Business ethics, Responsible lobbying 43 Compliance 2012 CSR Report – Ethics, Business ethics, Responsible lobbying 43 2012 CSR Report – Patient, Patient safety, Drug safety monitoring 30 2012 CSR Report – Patient, Patient safety, Product quality 33 Product responsibility Customer health and safety Download Center – Global quality policy Product and service labelling Marketing communications 2012 CSR Report – Patient, Patient safety, Product quality 33 Download Center – Global quality policy 2012 CSR Report – Ethics, Business ethics, Responsible marketing 46 2012 CSR Report – Patient, Patient safety, Product quality 33 Download Center – Global quality policy 2012 CSR Report – Ethics, Business ethics, Responsible marketing Customer privacy Data protection charter, FAQ about Clinical Trials Compliance 2012 CSR Report – Patient, Patient safety, Product quality 46 We follow good clinical practises in line with the Helsinki declaration. 33 8 GLOBAL REPORTING INITIATIVE Standard disclosures part iii: performance indicators Indicator Disclosure Level of reporting Location of disclosure Page Direct economic value generated and distributed, including revenues, operating costs, employee compensation, donations and other community investments, retained earnings, and payments to capital providers and governments. Form 20-F 2012 – Part I - Item 3 - (http://en.sanofi.com/investors/ news/news.aspx) 2 Financial implications and other risks and opportunities for the organization’s activities due to climate change. Download Center – Energy carbon footprint factsheet Economic Economic performance EC1 EC2 Download Center – Risk management system factsheet EC3 Coverage of the organization’s defined benefit plan obligations. Form 20-F 2012 – Part I - Item 4 - (http://en.sanofi.com/investors/ news/news.aspx) 31 Market presence EC6 Policy, practices, and proportion of spending on locally-based suppliers at significant locations of operation. Registation document 2012 – Section 4.3.3 – (http://en.sanofi. com/investors/news/news.aspx) 366 361 Indirect economic impacts EC8 Development and impact of infrastructure investments and services provided primarily for public benefit through commercial, in-kind, or pro bono engagement. Registation Document 2012 – Section 4.3.1 – (http://en.sanofi. com/investors/news/news.aspx) EC9 Understanding and describing significant indirect economic impacts, including the extent of impacts. 2012 CSR Report – Patient, Access to healthcare 13 Environmental Materials EN1 Materials used by weight or volume. 2012 CSR Report – Our CSR performance, Our indicators 89 EN2 Percentage of materials used that are recycled input materials. 2012 CSR Report – Our CSR performance, Our indicators 89 EN3 Direct energy consumption by primary energy source. 2012 CSR Report – Our CSR performance, Our indicators 89 EN4 Indirect energy consumption by primary source. 2012 CSR Report – Our CSR performance, Our indicators 89 EN7 Initiatives to reduce indirect energy consumption and reductions achieved. 2012 CSR Report – Planet, Energy and carbon footprint 71 EN8 Total water withdrawal by source. 2012 CSR Report – Our CSR performance, Our indicators 89 EN9 Water sources significantly affected by withdrawal of water. 2012 CSR Report – Planet, Water management 78 Energy Water 9 GLOBAL REPORTING INITIATIVE Indicator Disclosure Level of reporting Location of disclosure Page Biodiversity Location and size of land owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas. Download Center – Biodiversity and biopiracy factsheet EN12 Description of significant impacts of activities, products, and services on biodiversity in protected areas and areas of high biodiversity value outside protected areas. 2012 CSR Report – Planet, Pharmaceuticals in the environment EN13 Habitats protected or restored. Download Center – Sanofi position on biodiversity and biopiracy factsheet EN14 Strategies, current actions, and future plans for managing impacts on biodiversity. Download Center – Sanofi position on biodiversity and biopiracy factsheet EN15 Number of IUCN Red List species and national conservation list species with habitats in areas affected by operations, by level of extinction risk. 2012 CSR Report – Our CSR performance, Our indicators EN11 Three of the Group’s industrial sites, Swiftwater (US), Vertolaye (France), and Csanyikvolgy (Hungary), are located in environmentally protected zones/areas where environmental regulations are more stringent in order to preserve the natural resources surrounding these sites. They are under particular scrutiny as a result of their location. 81 90 Download Center – Sanofi position on biodiversity and biopiracy factsheet Emissions, effluents and waste EN16 Total direct and indirect greenhouse gas emissions by weight. 2012 CSR Report – Our CSR performance, Our indicators 90 EN17 Other relevant indirect greenhouse gas emissions by weight. 2012 CSR Report – Our CSR performance, Our indicators 90 EN18 Initiatives to reduce greenhouse gas emissions and reductions achieved. 2012 CSR Report – Planet, Energy and carbon footprint 71 EN19 Emissions of ozone-depleting substances by weight. This is <1 tonne. A more precise figure is not relevant as it has such a minor impact. EN20 NOx, SOx, and other significant air emissions by type and weight. 2012 CSR Report – Our CSR performance, Our indicators 90 EN21 Total water discharge by quality and destination. 2012 CSR Report – Planet, Water management 78 2012 CSR Report – Our CSR performance, Our indicators 90 90 EN22 Total weight of waste by type and disposal method. 2012 CSR Report – Our CSR performance, Our indicators EN23 Total number and volume of significant spills. Number of uncontrolled environmental releases to air land or water resulting in information to local authorities 4 in 2010 0 in 2011 6 in 2012 Products and services EN26 Initiatives to mitigate environmental impacts of products and services, and extent of impact mitigation. 2012 CSR Report – Planet, Pharmaceuticals in the environment 81 2012 CSR Report – Our CSR performance, Our indicators 90 10 GLOBAL REPORTING INITIATIVE Indicator Disclosure Level of reporting Location of disclosure Page Compliance EN28 Monetary value of significant fines and total number of nonmonetary sanctions for non-compliance with environmental laws and regulations. The monetary value of fines and total number of non-monetary sanctions for non-compliance with environmental laws and regulations is not significant. Significant environmental impacts of transporting products and other goods and materials used for the organization’s operations, and transporting members of the workforce. 2012 CSR Report – Planet, Energy and carbon footprint 71 2012 CSR Report – Our CSR performance, Our indicators 90 2012 CSR Report – Our CSR performance, Our indicators 90 Transport EN29 Overall EN30 Total environmental protection expenditures and investments by type. Social: Labor Practices and Decent Work Employment LA1 Total workforce by employment type, employment contract, and region, broken down by gender. Registation Document 2012 – Section 4.1.1 – (http://en.sanofi. com/investors/news/news.aspx) 331 LA2 Total number and rate of new employee hires and employee turnover by age group, gender, and region. Registation Document 2012 – Section 4.1.1 – (http://en.sanofi. com/investors/news/news.aspx) 331 Registation Document 2012 – Section 4.1.3 – (http://en.sanofi. com/investors/news/news.aspx) 340 Rates of injury, occupational diseases, lost days, and absenteeism, and number of work-related fatalities by region and by gender. Registation Document 2012 – Section 4.1.4 – (http://en.sanofi. com/investors/news/news.aspx) 343 Education, training, counseling, prevention, and risk-control programs in place to assist workforce members, their families, or community members regarding serious diseases. Need to include the table from the guidelines to be ‘fully’ Labor/management relations LA4 Percentage of employees covered by collective bargaining agreements. Occupational health and safety LA7 LA8 Training and education LA10 Average hours of training per year per employee by gender, and by employee category. 2012 CSR Report – Our CSR performance, Our indicators 87 LA11 Programs for skills management and lifelong learning that support the continued employability of employees and assist them in managing career endings. 2012 CSR Report – People, Workforce development 66 LA12 Percentage of employees receiving regular performance and career development reviews, by gender. 2012 CSR Report – People, Workforce development 66 100% of employees of both genders receive annual performance reviews. Diversity and equal opportunity LA13 Composition of governance bodies and breakdown of employees per employee category according to gender, age group, minority group membership, and other indicators of diversity. 2012 CSR Report – People, Diversity As a French company we are not allowed to collect ethnicity data but we do collect it at US affiliate level. 60 11 GLOBAL REPORTING INITIATIVE Indicator Disclosure Level of reporting Location of disclosure Page Social: Human Rights Investment and procurement practices HR1 Percentage and total number of significant investment agreements and contracts that include clauses incorporating human rights concerns, or that have undergone human rights screening. Download Center – Responsible procurement factsheet HR2 Percentage of significant suppliers, contractors and other business partners that have undergone human rights screening, and actions taken. 2012 CSR Report – Ethics, Human rights 50 100% of our suppliers and contractors receive our supplier code of conduct which includes human rights aspects. In 2012 354 suppliers were identified to undergo CSR evaluation and 18% (65) had to implement corrective action plans. HR3 Total hours of employee training on policies and procedures concerning aspects of human rights that are relevant to operations, including the percentage of employees trained. 8 hours per employee 2012 CSR Report – Ethics, Human rights 50 2012 CSR Report – Our CSR performance, Our indicators 87 Non-discrimination HR4 Total number of incidents of discrimination and actions taken. Freedom of association and collective bargaining HR5 Operations and significant suppliers identified in which the right to exercise freedom of association and collective bargaining may be violated or at significant risk, and actions taken to support these right. A risk analysis of suppliers has been performed. ECOVADIS is used on the suppliers and in the countries of operaton identified as high risk. Operations and significant suppliers identified as having significant risk for incidents of child labor, and measures taken to contribute to the effective abolition of child labor. A risk analysis of suppliers has been performed. ECOVADIS is used on the suppliers and in the countries of operaton identified as high risk. Child labor HR6 Forced and compulsory labor HR7 Operations and significant suppliers identified as having significant risk for incidents of forced or compulsory labor, and measures to contribute to the elimination of all forms of forced or compulsory labor. A risk analysis of suppliers has been performed. ECOVADIS is used on the suppliers and in the countries of operaton identified as high risk. Percentage and total number of operations that have been subject to human rights reviews and/or impact assessments. More than 7 functions have been subject to Human Rights assessment at corporate and local level (legal, human resources, security, R&D, Public Affairs, Supply Chain, Pharmacovigilance, Marketing, etc). Assessment HR10 Social: Society Local communities SO1 Percentage of operations with implemented local community engagement, impact assessments, and development programs. 2012 CSR Report – Patient, Access to healthcare 13 Percentage of employees trained in organization's anti-corruption policies and procedures. 2012 CSR Report – Ethics, Business ethics, Responsible lobbying 43 2012 CSR Report – Our CSR Performance, Our indicators 87 Corruption SO3 12 GLOBAL REPORTING INITIATIVE Indicator Disclosure Level of reporting Location of disclosure Page 2012 CSR Report – Ethics, Business ethics, Responsible lobbying 43 Total number of legal actions for anti-competitive behavior, antitrust, and monopoly practices and their outcomes. Form 20-F 2012 – Part I - Item 8 - (http://en.sanofi.com/investors/ news/news.aspx) 198-201 Monetary value of significant fines and total number of nonmonetary sanctions for non-compliance with laws and regulations. Form 20-F 2012 – Part I - Item 8 - (http://en.sanofi.com/investors/ news/news.aspx) 198-201 30 Public policy SO5 Public policy positions and participation in public policy development and lobbying. Anti-competitive behavior SO7 Compliance SO8 Social: Product Responsibility Customer health and safety PR1 Life cycle stages in which health and safety impacts of products and services are assessed for improvement, and percentage of significant products and services categories subject to such procedures. 2012 CSR Report – Patient, Patient safety, Drug safety monitoring PR2 Total number of incidents of non-compliance with regulations and voluntary codes concerning health and safety impacts of products and services during their life cycle, by type of outcomes. 2012 CSR Report – Ethics, Ethics in R&D - Clinical trials 38 Product and service labelling PR3 Type of product and service information required by procedures, and percentage of significant products and services subject to such information requirements. 2012 CSR Report – Ethics, Business ethics, Responsible marketing 46 PR5 Practices related to customer satisfaction, including results of surveys measuring customer satisfaction. 2012 CSR Report – Patient, Patient safety, Product quality 33 2012 CSR Report – Ethics, Business ethics, Responsible marketing 46 Marketing communications PR6 Programs for adherence to laws, standards, and voluntary codes related to marketing communications, including advertising, promotion, and sponsorship.